Categories: Technology

Wix to Participate in a Fireside Chat at the 2026 Cantor Global Technology & Industrial Growth Conference

NEW YORK – – Wix.com Ltd. (NASDAQ: WIX), today announced that Wix management will participate in a fireside chat at the 2026 Cantor Global Technology & Industrial Growth Conference on Wednesday, March 11, 2026 at 4:10 pm ET. 

An archived replay will be available on Wix’s investor relations website: https://investors.wix.com.

About Wix.com Ltd.
Wix is a leading global platform for creating, managing, and growing a complete digital presence. Founded in 2006, Wix empowers millions of users, including self-creators, agencies, enterprises and more with industry-leading infrastructure, performance, and security. The platform combines advanced AI, flexible web design, domains, hosting, templates and robust business and commerce solutions to help users build stronger brands, connect with their audiences, and scale their businesses online. Wix is shaping the future of how digital experiences are built with its intuitive AI-powered website builder and no-code application creation through Base44, making sophisticated creation accessible.
For more about Wix, please visit our Press Room.

Media Relations Contact:  PR@wix.com  
Investor Relations Contact: IR@wix.com 

GlobeNews Wire

Recent Posts

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction,…

42 minutes ago

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as…

42 minutes ago

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)…

43 minutes ago

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

June 05, 2026 20:13 ET  | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up…

43 minutes ago